CIAM
IBIO icon

Caitong International Asset Management’s iBio IBIO Stock Holding History

Caitong International Asset Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Buy
+2
New +$5 ﹤0.01% 2330

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Caitong International Asset Management's IBIO Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in iBio (IBIO) in Q1 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #2330 among its holdings.

52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Caitong International Asset Management held 2 shares of iBio worth $4 as of Q1 2026.
  • iBio was a new Caitong International Asset Management position in Q1 2026.
  • iBio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2330 holding.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.